The partnership will foster collaborations on clinical applications for genome sequencing in oncology.
Robert B. Darnell, president and scientific director of NYGC, said in a news release: “The bio banking facility at RPCI will be a tremendous resource to learn about genetic origins and new treatments for cancer patients, and it will expand the possibilities for important large-scale cancer genomic studies conducted at NYGC and with our collaborating members institutions.”
More Articles on Cancer Centers:
Trinitas Comprehensive Cancer Center Joins Jefferson Kimmel Cancer Center Network
University of Michigan Launches State’s First Cardio-Oncology Clinic
North Shore-LIJ to Invest $175M in Cancer Institute
